Research and Markets (http://www.researchandmarkets.com/research/4fwbpm/molecular) has announced the addition of the "Molecular Diagnostic Market and Testing" report to their offering.
This report focuses on market background of the areas that are covered, including lung, breast, thyroid and blood cancers (specifically leukemia and lymphoma), as well as pre-conception genetic information and prenatal diagnostics.
Included in this Report:
- Cancer diagnostics companies interviewed include: GeneCentric, Veracyte, Adaptive Biotechnologies.
- Genetic and prenatal diagnostics research companies, including GenePeeks and Verinata Health.
- Comprehensive coverage of survey results (n=123) from the various companies and researchers working in molecular diagnostics.
- A company directory which was created for this report. This includes several seasoned and emerging companies, their areas of focus, and the status of their technologies.
Key Topics Covered:
Part I: Introduction And Market Background
Chapter 1: The Focus Of This Report
Chapter 2: Market Trends And Adaptability
Part II: Cancer Diagnostics
Chapter 3: Lung Cancer
Chapter 4: Breast Cancer
Chapter 5: GeneCentric
Chapter 6: Thyroid Cancer
Chapter 7: Veracyte
Chapter 8: Blood-Based Cancers
Chapter 9: Adaptive Biotechnologies Corporation
Part III: Genetic Information And Prenatal Diagnostics
Chapter 10: Genetic Information And Prenatal Testing
Chapter 11: GenePeeks
Chapter 12: Verinata Health
Chapter 13: Testing Specifications
Part IV: Survey Demographics
Chapter 14: Survey Results
Part V: Company Directory
For more information visit http://www.researchandmarkets.com/research/4fwbpm/molecular.
